<DOC>
	<DOCNO>NCT01751360</DOCNO>
	<brief_summary>To evaluate efficacy safety treatment SYR-472 diabetic patient .</brief_summary>
	<brief_title>SYR-472 Open-label Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>1 . The participant judge capable understanding comply protocol requirement investigator subinvestigator . 2 . The participant sign date write , informed consent form prior initiation study procedure . 1 . The participant concurrent serious cardiac disease , serious cerebrovascular disorder , serious pancreatic hematological disease . 2 . The participant assess ineligible study investigator subinvestigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>